Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDI200 in male infants with XLHED
NCT01775462Phase 2Completed
- Sponsor
- Edimer Pharmaceuticals
- Start
- Apr 2013
- Primary completion
- Dec 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 2 trial of EDI200 in X-linked hypohidrotic ectodermal dysplasia (XLHED), sponsored by Edimer Pharmaceuticals. Started Apr 2013; status: completed.
02
Drugs
EDI200
03
Conditions
X-linked hypohidrotic ectodermal dysplasia (XLHED)
Beyond the preview
Go deeper on NCT01775462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01775462.